2013 Stanford Hospital and Clinics (SHC) Cancer Innovation Fund Awards
As one outcome of the Cancer Services strategic planning process, the Stanford Hospital and Clinics (SHC) will create an Innovation Fund to support highly innovative research projects that have the promise to improve the lives of cancer patients.
This opportunity is available to all Stanford faculty and CPIC investigators who are members of the Cancer Institute and are eligible to conduct such research.
Projects must be directly patient-oriented and have the potential to provide significant clinical impact on the prevention, diagnosis, treatment or survival of cancer patients.
An Institutional Review Board (IRB) protocol for the study must be submitted prior to submitting an application and funding of approved projects will start following approval by the IRB and the SCI’s Scientific Review Committee (SRC).
A special committee will review all applications and scores will be based on the 9-scale NIH rating system. Criteria for selection include: degree of innovation, potential to have a major impact on cancer patients, availability of the patient population to be studied, appropriate metrics to evaluate the outcome, and qualifications of the investigators.
TIMELINE (Spring/Fall)
RFA posted February 2013 / August 2013
Application due March 15, 2013 / September 11, 2013 (both by 3pm)
Awards announced April 1, 2013 / October 3, 2013
Funding Available May 15, 2013 / November 15, 2013
Progress reports due June 17, 2014 / December 16, 2014
FUNDING
The SHC and SCI expect to fund two or three projects with each announcement with maximum awards in the $200,000 range. We make two announcements per year - spring and fall. The funding period will be for one year, beginning in May and November
Grant funds that are deemed necessary for the successful execution of the proposed project may be budgeted for:
(a) PI Salary Support (10% maximum of total grant)
(b) Equipment and supplies
(c) Communications
(d) Personnel for research assistance; and
(e) Other purposes
Unused funds will revert back to the Innovation fund. All proposed expenses must conform to the general policies of the University and the Stanford Cancer Institute.
RFA / APPLICATION PROCESS / FORMS
Please refer to 2013 Innovation RFA for additional funding, eligibility, and application submission process information. All required documents and forms are located below.
2013 Innovation RFA (to be supplied)
2013 Innovation Coverpage (to be supplied)
NIH biosketch sample (June 2009)
For additional information regarding Stanford Hospital and Clinics (SHC) Cancer Innovation Fund Awards, please contact Denise Baughman at deniseb@stanford.edu.
Trial Administration